We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Says Janssen Alzheimer's Patent Invalid

Law360 (August 28, 2008, 12:00 AM EDT) -- A federal judge has ruled that Janssen Pharmaceutica Inc.'s Alzheimer's drug patent is invalid for lack of enablement in a victory for several generic-drug makers accused of infringing the patent.

Judge Sue Robinson ruled against Janssen in the U.S. District Court for the District of Delaware in a consolidated case the company had filed against several generics makers over Alzheimer's drug Razadyne.

In 2005, the defendant drug companies filed abbreviated new drug applications with the U.S. Food and Drug Administration to make generic versions of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.